| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Keros Therapeutics, Inc. (KROS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 92 sells. KROS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 759.2K | $8.09M | - | |
| Dir | 759.2K | $8.09M | - | |
| Dir | 102.2K | $1.09M | - | |
| CEO | 62.5K | $665.6K | - | |
| Dir | 17.6K | $187.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 | Knowles Julius62 | Director | Sell | 47,651 | $57.84 | $2,756,115.99 | -0.7% | +12.3% | -18.8% | |
| Dec 15, 2021 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 2,650 | $50.40 | $133,558.26 | -0.8% | -2.7% | -4.9% | |
| Dec 2, 2021 | Knowles Julius62 | Director | Sell | 47,651 | $54.09 | $2,577,375.56 | -0.9% | -4.2% | -5.6% | |
| Nov 11, 2021 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 21,200 | $59.91 | $1,270,058.05 | -7.5% | -8.7% | -22.3% | |
| Nov 4, 2021 | Lachey Jennifer69 | Chief Scientific Officer | Sale+OE | 10,600 | $50.00 | $530,000.00 | -11.0% | -11.8% | -8.4% | |
| Nov 3, 2021 | Knowles Julius62 | Director | Sell | 47,651 | $42.12 | $2,007,129.32 | -1.1% | +18.7% | +21.4% | |
| Oct 20, 2021 | Knowles Julius62 | Director | Sell | 8,598 | $38.20 | $328,440.86 | -0.3% | +26.6% | +15.1% | |
| Oct 18, 2021 | Knowles Julius62 | Director | Sell | 26,367 | $38.56 | $1,016,652.69 | -0.6% | +27.6% | +20.7% | |
| Oct 5, 2021 | Knowles Julius62 | Director | Sell | 12,686 | $40.10 | $508,754.95 | -0.6% | +49.0% | +0.5% | |
| Sep 27, 2021 | Knowles Julius62 | Director | Sell | 95,302 | $41.17 | $3,924,003.27 | -3.9% | +34.3% | -19.2% |